Cargando…
Regulatory scientists’ work has important ramifications for public health and should be open to public scrutiny
The Swedish Medical Products Agency (MPA) objects to the fact that we occasionally refer to one of its senior ex-employees by name. However, names of individual MPA assessors, Food and Drug Administration (FDA) reviewers, and European Medicines Agency rapporteurs and co-rapporteurs are cited in regu...
Autores principales: | Mulinari, Shai, Davis, Courtney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237023/ https://www.ncbi.nlm.nih.gov/pubmed/30428900 http://dx.doi.org/10.1186/s12961-018-0371-4 |
Ejemplares similares
-
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of ‘deep’ product reviews
por: Mulinari, Shai, et al.
Publicado: (2017) -
Spot on for liars! How public scrutiny influences ethical behavior
por: Ostermaier, Andreas, et al.
Publicado: (2017) -
Violence against doctors – Implementation of law needs scrutiny
por: Gupta, Harish, et al.
Publicado: (2022) -
Conceptual unclarity about COVID-19 ethnic disparities in
Sweden: Implications for public health policy
por: Bredström, Anna, et al.
Publicado: (2022) -
Should Publication be the Only Means of Assessment?
por: Patra, Bichitra Nanda, et al.
Publicado: (2013)